Archives

by in
Entry Author Date Location
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
Dip, But No Slowdown in First-Quarter VC Funding, & Top 10 Deals 04/17/15 National
Doudna, Berkeley Gain Expert’s Backing In CRISPR Patent Fight 04/15/15 San Francisco
Big Day For Biotech IPOs as Aduro More Than Doubles In Price 04/15/15 San Francisco
Announcing Boston 2035: Innovating the Future Starts Now 04/15/15 Boston
What’s Hot in Boston Biotech: The Photos 04/15/15 Boston
Massachusetts Healthcare, Internet Companies Lead Pack in VC Chase 04/14/15 Boston
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
VC Funding Slows as Big Funds Crowd into Late-Stage Venture Deals 04/14/15 National
Curoverse Begins Trial Run for Open Source Genomics Tool 04/14/15 Boston
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
Blend Therapeutics Taps Former Clinical Data Chief Fromkin As New CEO 04/13/15 Boston
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
Startups Strut on Stage at UNC Innovation Showcase 04/10/15 Raleigh Durham
Seven Takeaways From “What’s Hot in Boston Biotech” 04/10/15 Boston
Edge Brings in VC Backers, Gets $72.5M For Head Injury Drug 04/09/15 New York
Alzheon Gets $10M to Take Castoff Alzheimer’s Drug Into Pivotal Test 04/08/15 Boston
Juno, Novartis End CAR-T Patent Fight, With Juno A Little Richer 04/06/15 Seattle
Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal 04/06/15 New York
East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More 04/03/15 Boston
Doudna’s Caribou Bio Raises $11M To Expand Uses For Gene Editing Tech 04/02/15 San Francisco
ZappRx Nabs $5.6M, Inks Zafgen Deal to E-Prescribe Obesity Meds 04/02/15 Boston
Days After $22M Raise, Gelesis Files for IPO 04/01/15 Boston
Equity Crowdfunding Backers Clash Over Fundraising Limits in States 04/01/15 National
Garabedian’s Rocky Road at Sarepta Ends With Abrupt Resignation 04/01/15 Boston
Xconomy Boston’s Top Stories of Q1 2015: Editor’s Picks 04/01/15 Boston
Fresh Off Boston Move, CoLucid Plots IPO For Migraine Drug Push 03/31/15 Raleigh Durham
Spruce Nabs $15M Series A to Connect Dermatologists and Patients 03/31/15 San Francisco
Pivoting From IPO, Syndax Inks Combo Trial Deal With Merck 03/31/15 Boston
From Iceland to White House, Precision Medicine’s Promises & Hurdles 03/31/15 National
Page 1 of 94 next page »